Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure

Kenichi Matsushita, Kazumasa Harada, Tetsuro Miyazaki, Takamichi Miyamoto, Shun Kohsaka, Kiyoshi Iida, Shuzou Tanimoto, Makoto Takei, Toru Hosoda, Yoshiya Yamamoto, Yasuyuki Shiraishi, Hideaki Yoshino, Takeshi Yamamoto, Ken Nagao, Morimasa Takayama

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: No agents have been proven to improve survival in heart failure with preserved ejection fraction (HFpEF), but the phenotypic diversity of HFpEF suggests it may be possible to identify specific HFpEF phenotypes that will benefit from certain treatments. This study compared the risk factors for and prognostic impacts of treatments on in-hospital mortality between HFpEF patients with (R) and without (-) high blood pressure (HBP). Methods: Data on 2238 consecutive HFpEF patients were extracted from Tokyo CCU Network data registry and analysed. HFpEF was defined as an ejection fraction greater than or equal to 50%; HBP was defined as elevated systolic blood pressure (>140 mmHg) at admission. Potential risk factors for in-hospital mortality were selected by univariate analyses and those with P <0.10 were used in multivariate Cox regression analysis with forward selection (likelihood ratio) to identify significant factors. Results: In-hospital mortality was significantly lower for HFpEF R HBP than HFpEF - HBP patients (log-rank, P<0.001). Independent risk factors for in-hospital mortality in HFpEF R HBP patients were older age (hazard ratio 1.069) and in-hospital treatment without betablockers (hazard ratio 7.946), whereas older age (hazard ratio 1.035), higher C-reactive protein (hazard ratio 1.047), higher B-type natriuretic peptide (hazard ratio 1.000) and in-hospital treatment without diuretics (hazard ratio 4.201) were identified as independent risk factors in HFpEF - HBP patients. Conclusion: There were significant differences in prognostic factors, including beta-blocker and diuretic treatments, for in-hospital mortality between HFpEF patients with and without HBP. These findings suggest possible individualized therapies for patients with HFpEF.

Original languageEnglish
Pages (from-to)643-649
Number of pages7
JournalJournal of hypertension
Volume37
Issue number3
DOIs
Publication statusPublished - 2019 Mar

Keywords

  • Beta-blockers
  • Diuretics
  • Heart failure with preserved ejection fraction
  • Hypertension
  • Mortality

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure'. Together they form a unique fingerprint.

  • Cite this

    Matsushita, K., Harada, K., Miyazaki, T., Miyamoto, T., Kohsaka, S., Iida, K., Tanimoto, S., Takei, M., Hosoda, T., Yamamoto, Y., Shiraishi, Y., Yoshino, H., Yamamoto, T., Nagao, K., & Takayama, M. (2019). Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure. Journal of hypertension, 37(3), 643-649. https://doi.org/10.1097/HJH.0000000000001932